The Norwegian Vitamin Trial (NORVIT)

• Status: Completed
• Trial end date: 2004-03-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to examine whether the lowering of blood homocysteine levels by treatment with B vitamins can prevent cardiovascular disease

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: University of Tromso
• Collaborators: Foundation to Promote Research into Functional Vitamin B12 Deficiency, Bergen, Norway; The Council on Health and Rehabilitation, Norway; The International Federation of Red Cross and Red Crescent Societies; The Norwegian Council on Cardiovascular Disease; The Research Council of Norway; The Royal Norwegian Ministry of Health
• Treatments: Folic Acid; Hydroxocobalamin; Pyridoxal; Pyridoxine; Vitamin B 12; Vitamin B 6; Vitamin B Complex; Vitamins

Criteria

Inclusion Criteria:

• Acute myocardial infarction within 7 days prior to randomization

• Men and women aged 30-85 years

• Written informed consent

Exclusion Criteria:

• Coexisting disease that shortens expected survival to less than 4 years

• Ongoing treatment with B vitamins

• Expected poor compliance